ICIS is my favorite Society I am involved in, and I am very honored to have received the Amanda Proudfoot Tribute Award for Advances in Chemokine Biology during Cytokines 2023 Conference. This award provides valuable support for my job hunting and encourages me to continue working on cytokines in the [READ MORE]
Join us for Cytokines 2024 / KAI 2024 and be inspired by an exceptional lineup of confirmed speakers. Share your cytokine research with over 2,000 participants from around the world by submitting an abstract for oral or poster presentation by the Abstract Submission and Student Member Travel Award application deadline of May 20, 2024. [READ MORE]
Long time ICIS member, Alberto Mantovani, was recently elected into the National Academy of Sciences (NAS) in recognition of his distinguished achievements in original research. See the May 3 issue of the Signals+ Newsletter for more on that honor. This issue, we’re pleased to feature Prof. Emeritus Mantovani in the [READ MORE]
In the Phase 2 CITYSCAPE trial, Tiragolumab, an anti-TIGIT antibody, demonstrated efficacy when combined with Atezolizumab, an anti-PD-L1, compared to Atezolizumab alone for the treatment of non-small cell lung carcinoma. In mouse models, inhibition of both the TIGIT and PD-1 pathways was shown to synergistically function to reinvigorate T cell [READ MORE]
I am a fan of musical theatre, and scientific meetings definitely have some aspect of performance – just imagine if speakers had to sing their talks? Perhaps a musical about cytokines could be the next hot thing to come to Broadway or the West End? Here are some proposed titles: [READ MORE]
Signals+ Editorial Board member, Maialen Sebastian, recently caught up with a 2023 ICIS-Pfizer Junior Investigator Award recipient, Iolanda Miceli for this interview. “I am concurrently completing my medical degree and scientific training at Monash University Melbourne. I never anticipated that my medical degree would morph into a PhD program as [READ MORE]
Students and Postdoctoral Researchers presenting novel and promising research may apply to receive a travel award to partially cover travel expenses. [READ MORE]
Have You Started Making Your Plan to Attend Cytokines 2024 / KAI 2024? Here’s Two More “Must Visit” Places in Seoul – and the latest list of symposia speakers confirmed by the Cytokine 2024 secretariat. [READ MORE]
Prof. Michael Gale, Jr. to head University of Minnesota’s Department of Microbiology and Immunology and become Director of the Institute on Infectious Diseases [READ MORE]
There have been many great (Cytokines) meetings for different reasons. But the standout for me was Hawaii 2022. It was the first face-to-face meeting post COVID lockdown era and Melbourne had one of the longest at 265 days!!! So this was the first time we had seen our international family in over 3 years! The excitement was palpable. It brought home all the values of our Science and this Society. [READ MORE]
International Cytokine & Interferon Society, Copyright 2024 Website Design by Rhema Association Management | Privacy Policy
